Intas Pharmaceuticals Ltd has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public offering of its equity shares of face value Rs.10 each comprising a fresh issue of equity shares aggregating up to Rs.425 crore and an Offer for Sale of 5,810,550 equity shares by Mozart Limited.
The Issue, will be made through a 100 per cent book building process wherein not more than 50 per cent of the issue shall be allocated on a proportionate basis to qualified institutional buyers, not less than 15 per cent of the issue shall be allocated to non-institutional bidders and not less than 35 per cent of the issue shall be available to retail individual bidders.
Kotak Mahindra Capital Company Limited and Morgan Stanley India Company Private Limited are the book running lead managers to the Issue.